Women with pulmonary arterial hypertension (PAH) secondary to congenital heart disease (PAH-CHD) are at a high…
Articles by Ana Pena, PhD
The heart’s ventricular mass may be an early prognostic biomarker for predicting the risk of heart…
Variations in a gene called FIGNÂ predispose to familial or heritable pulmonary arterial hypertension (FPAH)Â in carriers of the p.Arg491Gln…
Heart defects that develop before birth may lead to a variety of complications later in life, including pulmonary hypertension (PH), according…
Women’s pulmonary artery muscle cells produce more of a signal molecule called hypoxia-inducible factor 1-alpha (HIF1α), which may…
Spouses of people with pulmonary arterial hypertension (PAH) and…
United Therapeutics has now acquired worldwide rights over ralinepag, a potential oral…
Biotechnology company Morphogen-IXÂ has raised $23.2 million to advance development of its lead drug…
Switching treatment from United Therapeutics’ Tyvaso (inhaled…
Revatio (sildenafil) in low doses is safe and can be of benefit to children with pulmonary hypertension (PH), particularly those with…
Treprostinil is a therapy that works to reduce pulmonary artery narrowing in people with pulmonary arterial hypertension…
Liquidia Technologies has completed the enrollment for the safety part of a Phase 3 trial…